InnoWL secured seed funding from CNTTech and DB Capital to scale its AI-driven RNA diagnostic platfo...
The AMW Read
This updates the player map for the Healthcare/Bio vertical with a seed-stage startup focused on non-invasive RNA diagnostics, though the funding amount does not trigger a cross.§D tag.
NoveltySignificance
Healthcare & Bio · Player Map
InnoWL secured seed funding from CNTTech and DB Capital to scale its AI-driven RNA diagnostic platform for atopic dermatitis. Using microneedles and transcriptome analysis, the startup provides objective subtyping for 1M+ Korean patients. This shift from invasive biopsies to non-invasive molecular mapping supports targeted therapies by 2028. Systemically, it transforms diagnosis into a data-driven asset for pharmaceutical R&D and precision medicine. 🧬